SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Sprechen Sie mit dem Deal Team
Transaktionen
Mutigny Resort Hotel has raised funds to construct a new 4-star hotel in Champagne
Mutigny Resort Hotel (MRH) has raised funds to construct a new 4-star hotel in Champagne. This involved agreements with the promoter, Artec Groupe, the operator, Loisium Wine & Spa Hotels, bank debt with Caisse d'Epargne Grand-Est Europe, Banque Postale and Arkea, and equity with La Banque des territoires, Merimee and Artec Groupe.
Mehr erfahrenEterus Capital has acquired a minority stake in eyerim
Eterus Capital has acquired a minority stake in eyerim.
Mehr erfahrenJacques Remy & fils acquired by a Belgian diversified fruit and vegetables group
The shareholders of Jacques Remy & fils have sold the company to a group of Belgian investors active in the fruits and vegetables sector.
Mehr erfahren